Inside Madrigal Pharma: CEO Sibold’s Routine RSU Sales Show Steady Tax Planning, Not Market Timing
Insider sales at Madrigal Pharma show CEO William Sibold’s routine tax‑withholding trades—no market timing, steady holdings, and a steady view on future growth.
- MADRIGAL PHARMACEUTICALS INC
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- AI generated
4 minutes to read